IL33 and myocardial infarction: By restricting caspase-3 function and boosting the generation of the 'inhibitor of cell death' (IAP) group of proteins, IL-33 can potentially diminish the demise of heart muscle cells, lessen heart attack damage and scarring, and improve the pumping ability of the ventricle in a living organism.